Medtronic Announces FDA Approval and Launch of Its Advisa MRI Pacemaker System

Medtronic, Inc. (NYSE: MDT), today announced FDA approval and U.S. launch of its Advisa DR MRI™ SureScan® pacing system. The Advisa MRI system is Medtronic's second-generation MR-Conditional pacemaker and is the first system to combine the most advanced pacing technology with proven MRI access.

Source: News from Angioplasty.Org - February 14, 2013 Category: Cardiology Source Type: news